Injective: Three U.S. INJ ETF applications are filed - 08 Oct 2026
As of October 8, 2026, three U.S. ETF applications for Injective's INJ token are officially filed and pending approval. The applications are from 21Shares, Canary and REX-Osprey.The filings broaden the proposed routes to institutional access, with three applicants seeking approval rather than a sin…
As of October 8, 2026, three U.S. ETF applications for Injective's INJ token are officially filed and pending approval. The applications are from 21Shares, Canary and REX-Osprey.The filings broaden the proposed routes to institutional access, with three applicants seeking approval rather than a sin…
What's Your Reaction?
